RUNX3 and acute myeloid leukemia: On the contrary, we observed DEU of 6 exon bins in RUNX3 for AML-ASXL1 blood samples (Fig. 4D, Table S7) which corresponded to higher usage of the last exons (Fig. 4D, Table S8), and lower usage of the first exon (Fig. 4E).